HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jorge C G Blanco Selected Research

eritoran

1/2019Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.
5/2013The TLR4 antagonist Eritoran protects mice from lethal influenza infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jorge C G Blanco Research Topics

Disease

26Infections
01/2022 - 06/2002
14Respiratory Syncytial Virus Infections
12/2021 - 06/2002
11Human Influenza (Influenza)
01/2021 - 10/2005
6Inflammation (Inflammations)
05/2013 - 06/2002
4Virus Diseases (Viral Diseases)
01/2018 - 12/2006
3Acute Lung Injury
01/2019 - 05/2013
3Pneumonia (Pneumonitis)
04/2010 - 10/2005
3Reinfection
01/2008 - 06/2007
2Bacterial Infections (Bacterial Infection)
01/2019 - 08/2003
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2018 - 01/2016
2Cytokine Release Syndrome
03/2014 - 06/2006
2Communicable Diseases (Infectious Diseases)
06/2009 - 01/2004
2Coinfection
11/2007 - 06/2002
1Conjunctivitis
01/2022
1Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2021
1Demyelinating Diseases (Demyelinating Disease)
12/2019
1Herpes Labialis (Fever Blister)
12/2019
1Superinfection
01/2019
1Narcolepsy
01/2017
1Herpes Genitalis (Genital Herpes)
10/2015
1Autoimmune Diseases (Autoimmune Disease)
01/2012
1Bronchiolitis
01/2012
1HIV Infections (HIV Infection)
05/2009
1Bacteremia
11/2007
1Hypothermia
11/2007
1Latent Infection
09/2007
1Lung Diseases (Lung Disease)
06/2007
1Interstitial Lung Diseases (Interstitial Lung Disease)
06/2007
1Tuberculosis (Tuberculoses)
03/2007
1Necrosis
10/2005
1Paramyxoviridae Infections (Parainfluenza)
12/2002

Drug/Important Bio-Agent (IBA)

17VaccinesIBA
01/2021 - 06/2007
8CytokinesIBA
01/2016 - 06/2002
7Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2002
7Antiviral Agents (Antivirals)IBA
01/2021 - 12/2005
7Messenger RNA (mRNA)IBA
01/2019 - 06/2002
7InterferonsIBA
01/2014 - 06/2002
4Influenza Vaccines (Influenza Vaccine)FDA Link
01/2021 - 05/2013
4ChemokinesIBA
01/2019 - 06/2002
4Indicators and Reagents (Reagents)IBA
01/2013 - 01/2004
3Toll-Like Receptor 4IBA
01/2019 - 01/2012
3Formaldehyde (Formol)FDA Link
06/2010 - 06/2006
2eritoranIBA
01/2019 - 05/2013
2Phospholipids (Phosphatides)FDA LinkGeneric
01/2018 - 05/2013
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2008
2Neutralizing AntibodiesIBA
01/2016 - 06/2007
2monophosphoryl lipid AIBA
03/2014 - 06/2006
2Respiratory Syncytial Virus VaccinesIBA
06/2010 - 06/2006
2Interferon Type IIBA
01/2008 - 12/2006
2Interleukin-10 (Interleukin 10)IBA
11/2007 - 10/2005
2Interleukin-6 (Interleukin 6)IBA
11/2007 - 10/2005
2Interferon-gamma (Interferon, gamma)IBA
02/2007 - 12/2002
2InterleukinsIBA
02/2007 - 06/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2005 - 06/2002
2LipopolysaccharidesIBA
01/2004 - 08/2003
1GTP-Binding Proteins (G-Protein)IBA
12/2021
1Pattern Recognition ReceptorsIBA
01/2021
1Pathogen-Associated Molecular Pattern MoleculesIBA
01/2021
1FluLavalIBA
01/2021
1LigandsIBA
01/2021
1Inactivated VaccinesIBA
01/2021
1RNA Polymerase II (RNA Polymerase B)IBA
01/2019
1Interferon-betaIBA
01/2019
1Gastrin-Releasing PeptideIBA
01/2019
1FluMistIBA
01/2018
1EnzymesIBA
01/2018
1ImmunosorbentsIBA
01/2018
1Attenuated VaccinesIBA
01/2018
1HMGB1 Protein (HMG1)IBA
01/2018
1Immunoglobulin G (IgG)IBA
11/2015
1Glycoproteins (Glycoprotein)IBA
10/2015
1N,N-dimethyl-4-anisidine (DMPA)IBA
10/2015
1Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
10/2015
1E5564IBA
05/2013
1Pharmaceutical PreparationsIBA
01/2013
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2010
1Toll-Like Receptor 3IBA
04/2010
1poly ICLCIBA
04/2010
1Chemokine ReceptorsIBA
05/2009
1AntibodiesIBA
09/2007
1Viral RNAIBA
09/2007
1AerosolsIBA
03/2007
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2007
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2007
1Interleukin-4 (Interleukin 4)IBA
10/2005
1Interferon-alpha (Interferon Alfa)IBA
10/2005
1Chemokine CCL5IBA
10/2005
1Interleukin-1alpha (Interleukin 1 alpha)IBA
10/2005
1Chemokine CCL4IBA
10/2005
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2005
1Protein Isoforms (Isoforms)IBA
04/2005
1ProstaglandinsIBA
04/2005
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
04/2005
1Interleukin-1 (Interleukin 1)IBA
08/2003
1GlucocorticoidsIBA
12/2002
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
06/2002
1Complement System Proteins (Complement)IBA
06/2002

Therapy/Procedure

11Therapeutics
01/2019 - 12/2002
1Immunotherapy
12/2005